The Effects of Withdrawal of Dopaminergic Medication in Nursing Home Patients With Advanced Parkinsonism

Journal of the American Medical Directors Association

Volumn 9, Issue 9, 2008, Pages 670-675

  Tse, Winona ^a   Frisina, Pasquale G ^b   Hälbig, Thomas D ^a   Gracies, Jean Michel ^a   Liang, Lisa ^c   Tarshish, Chaim ^b   Lesser, Gerson ^b   Neufeld, Richard ^b   Koller, William C ^a   Libow, Leslie S ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Jewish Home and Hospital   (United States)

^c NONE

Author keywords

dementia; elderly population; levodopa; nursing home; Parkinsonism

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

AGED; ARTICLE; BEHAVIOR; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG FEVER; DRUG WITHDRAWAL; FEMALE; HUMAN; MALE; MENTAL HEALTH; MINI MENTAL STATE EXAMINATION; MOTOR PERFORMANCE; NEUROLOGIC EXAMINATION; NURSING HOME PATIENT; PARKINSONISM; PNEUMONIA; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SYMPTOM; UNIFIED PARKINSON DISEASE RATING SCALE; UNITED STATES;

EID: 55049140787     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2008.07.001     Document Type: Article

References (45)

1. Mutch W.J., Dingwall-Fordyce I., Downie A.W., et al. Parkinson's disease in a Scottish city. Br Med J 292 (1986) 534-536
2. Fall P.A., Axelson O., Fredriksson M., et al. Age-standardized incidence and prevalence of Parkinson's disease in a Swedish community. J Clin Epidemiol 49 (1996) 637-641
3. Tison F., Dartiques J.F., Dube L., et al. Prevalence of Parkinson's disease in the elderly. A population study in Gironde, France. Acta Neurol Scand 90 (1994) 111-115
4. Morgante L., Rocca W.A., and DiRosa A.E. Prevalence of Parkinson's disease and other types of parkinsonism: A door to door survey in three Sicilian municipalities. Neurology 42 (1992) 1901-1907
5. Mitchell S.L., Kiely D.K., Kiel D.P., et al. The epidemiology, clinical characteristics, and natural history of older nursing home residents with a diagnosis of Parkinson's disease. J Am Geriatr Soc 44 (1996) 394-399
6. Tse W., Libow L.S., Neufeld R., et al. Prevalence of movement disorders in an elderly nursing home population. Arch Gerontol Geriatr 46 (2008) 359-366
7. Lapane K.L., Fernandez H.H., and Friedman J.H. Prevalence, clinical characteristics, and pharmacologic treatment of Parkinson's disease in residents in long-term care facilities. SAGE Study Group. Pharmacotherapy 19 (1999) 1321-1327
8. Buchanan R.J., Wang S., Huang C., et al. Analysis of nursing home residents with Parkinson's disease using the minimum data set. Parkinsonism Relat Disord 8 (2002) 369-380
9. Findley L.J. The economic impact of Parkinson's disease. Parkinsonism Relat Disord 13 (2007) S8-S12
10. Findley L., Aujla M., Bain P.G., et al. Direct economic impact of Parkinson's disease: A research survey in the United Kingdom. Mov Disord 18 (2003) 1139-1145
11. Ahlskog J.E., and Muenter M.D. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov Disord 16 (2001) 448-458
12. Friedman J.H. The management of the levodopa psychoses. Clin Neuropharmacol 14 (1991) 283-295
13. Fenelon G., Mahieux F., Huon R., et al. Hallucinations in Parkinson's disease: Prevalence, phenomenology, and risk factors. Brain 123 (2000) 733-745
14. Sanchez-Ramos J.R., Ortoll R., and Paulson G.W. Visual hallucinations associated with Parkinson's disease. Arch Neurol 53 (2006) 1265-1268
15. Waters C.H. Treatment of advanced stage patients with Parkinson's disease. Parkinsonism Relat Disord 9 (2002) 15-21
16. Goetz C.G., and Stebbins S.T. Mortality and hallucinations in nursing home patients with advanced Parkinson's disease. Neurology 45 (1995) 669-671
17. Midlov P., Bondesson A., Eriksson T., et al. Descriptive study and pharmacotherapeutic intervention in patients with epilepsy or Parkinson's disease at nursing homes in southern Sweden. Eur J Clin Pharmacol 57 (2002) 903-910
18. Larsen J.P. Parkinson's disease as a community health problem: Study in Norwegian nursing homes. BMJ 303 (1991) 741-743
19. Croxson S. Warning on Parkinson's diagnosis. General Practitioner 27 (1989) 4
20. Quinn N. Parkinsonism-recognition and differential diagnosis. BMJ 310 (1995) 447-452
21. Hughs A.J., Daniel S.E., Kilford L., et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55 (1992) 181-184
22. Gibb W.R., and Lees A.J. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 51 (1988) 745-752
23. members of the UPDRS Development Committee, Fahn S., and Elton R.L. The Unified Parkinson's disease rating scale. In: Fahn S., Marsden C.D., Calne D.B., and Goldstein M. (Eds). Recent Developments in Parkinson's disease Vol. 2 (1987), MacMillan Healthcare Information, New Jersey 153-164
24. Martinez-Martin P., and Cubo E. Scales to measure parkinsonism. In: Koller W.C., and Melamed E. (Eds). Handbook of Clinical Neurology: Parkinson's disease and related disorders Vol 84 (2007), Elsevier, Amsterdam 291-327 (3rd series)
25. Hoehn M.M. The natural history of Parkinson's disease in the pre-levodopa and post-levodopa eras. Neurol Clin 10 (1992) 331-339
26. Folstein M.F., Folstein S.E., and McHugh P.R. "Mini-Mental State": A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12 (1975) 189-198
27. Boockvar K., Brodie H.D., and Lachs M. Nursing assistants detect behavioral changes in nursing home residents that precede acute illness. J Am Geriatr Soc 48 (2000) 1086-1091
28. Fern-Pollak L., Whone A.L., Brooks D.J., et al. Cognitive and motor effects of dopaminergic medication withdrawal in Parkinson's disease. Neuropsychologia 24 (2004) 1917-1926
29. Lange K.W., Paul G.M., Naumann M., et al. Dopaminergic effects on cognitive performance in patients with Parkinson's disease. J Neural Transm Suppl 46 (1995) 423-432
30. Lange K.W., Robbins T.W., Marsden C.D., et al. L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction. Psychopharmacology 107 (1992) 394-404
31. Kurlan R. Declining medication requirements in some patients with advanced Parkinson disease and dementia. Clin Neuropharmacol 26 (2003) 171
32. Tse W., and Koller W.C. Reply to "Declining medication requirements in some patients with advanced Parkinson disease and dementia.". Clin Neuropharmacol 27 (2004) 3
33. Olanow C.W., Watts R.L., and Koller W.C. An algorithm (decision tree) for the management of Parkinson's disease: Treatment guidelines. Neurology 56 (2001) S1-S88
34. Chen J.J., and Swope D.M. Pharmacotherapy for Parkinson's disease. Pharmacotherapy 27 (2007) 161S-173S
35. Goetz C.G., and Stebbins G.T. Risk factors for nursing home placement in advanced Parkinson's disease. Neurology 43 (1993) 2227-2229
36. Hely M.A., Morris J.G., Reid W.G., et al. Sydney Multicenter Study of Parkinson's disease: Non-l-dopa responsive problems predominate at 15 years. Mov Disord 20 (2005) 190-199
37. Braak H., Del Tredici K., Rub U., et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24 (2003) 197-211
38. Louis E.D., Marder K., Tabert M.H., et al. Mild parkinsonian signs are associated with lower olfactory test scores in the community-dwelling elderly. Mov Disord 23 (2008) 524-530
39. Rajput A., and Rajput A.H. Old age and Parkinson's disease. In: Koller W.C., and Melamed E. (Eds). Handbook of Clinical Neurology: Parkinson's Disease and Related Disorders Vol. 84 (2007), Elsevier, Amsterdam (3rd series)
40. Friedman J.H., Fernandez H.H., and Trieschmann M.M. Parkinsonism in a nursing home: Underrecognition. J Geriatr Psychiatry Neurol 17 (2004) 39-41
41. Esper C.D., and Factor S.A. Failure of recognition of drug-induced parkinsonism in the elderly. Mov Disord 23 (2008) 401-404
42. Levy G. The relationship of Parkinson disease with aging. Arch Neurol 64 (2007) 1242-1246
43. Blin J., Dubois B., Bonnet A.M., et al. Does ageing aggravate parkinsonian disability?. J Neurol Neurosurg Psychiatry 54 (1991) 780-782
44. Gomez Arevalo G., Jorge R., Garcia S., et al. Clinical and pharmacological differences in early- versus late-onset Parkinson's disease. Mov Disord 12 (1997) 277-284
45. Maesner J.E. Transient levodopa withdrawal in Parkinson's disease. [letter]. Clin Pharmacy 6 (1987) 22